Accelerating Adverse Outcome Pathway Development Using Publicly Available Data Sources

The adverse outcome pathway (AOP) concept links molecular perturbations with organism and population-level outcomes to support high-throughput toxicity (HTT) testing. International efforts are underway to define AOPs and store the information supporting these AOPs in a central knowledge base; however, this process is currently labor-intensive and time-consuming. Publicly available data sources provide a wealth of information that could be used to define computationally predicted AOPs (cpAOPs), which could serve as a basis for creating expert-derived AOPs in a much more efficient way. Computational tools for mining large datasets provide the means for extracting and organizing the information captured in these public data sources. Using cpAOPs as a starting point for expert-derived AOPs should accelerate AOP development. Coupling this with tools to coordinate and facilitate the expert development efforts will increase the number and quality of AOPs produced, which should play a key role in advancing the adoption of HTT testing, thereby reducing the use of animals in toxicity testing and greatly increasing the number of chemicals that can be tested.

[1]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[2]  Anushya Muruganujan,et al.  PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees , 2012, Nucleic Acids Res..

[3]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[4]  Martin Romacker,et al.  Evolving BioAssay Ontology (BAO): modularization, integration and applications , 2014, Journal of Biomedical Semantics.

[5]  Janan T. Eppig,et al.  GXD: a community resource of mouse Gene Expression Data , 2015, Mammalian Genome.

[6]  Sharon Munn,et al.  Adverse outcome pathway development II: best practices. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  J. Bailar,et al.  Toxicity testing in the 21st century—a vision and a strategy , 2012 .

[8]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[9]  M. Fielden,et al.  Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.

[10]  Judith A. Blake,et al.  The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease , 2014, Nucleic Acids Res..

[11]  Roger Schibli,et al.  Can animal data predict human outcome? Problems and pitfalls of translational animal research , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  S. Friend,et al.  A network view of disease and compound screening , 2009, Nature Reviews Drug Discovery.

[13]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[14]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[15]  Robert Petryszak,et al.  ArrayExpress update—simplifying data submissions , 2014, Nucleic Acids Res..

[16]  J. Pearl.  Causality: Models, Reasoning and Inference , 2000 .

[17]  Lon Phan,et al.  Phenotype–Genotype Integrator (PheGenI): synthesizing genome-wide association study (GWAS) data with existing genomic resources , 2013, European Journal of Human Genetics.

[18]  Wyeth W. Wasserman,et al.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles , 2004, Nucleic Acids Res..

[19]  Georgi Georgiev,et al.  PhenomicDB: a new cross-species genotype/phenotype resource , 2006, Nucleic Acids Res..

[20]  Jonathan D. Stallings,et al.  Systems Level Analysis and Identification of Pathways and Networks Associated with Liver Fibrosis , 2014, PloS one.

[21]  A. Nekrutenko,et al.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences , 2010, Genome Biology.

[22]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[23]  Janan T Eppig,et al.  The mammalian phenotype ontology: enabling robust annotation and comparative analysis , 2009, Wiley interdisciplinary reviews. Systems biology and medicine.

[24]  Daniel J. Blankenberg,et al.  Galaxy: a platform for interactive large-scale genome analysis. , 2005, Genome research.

[25]  Pietro Liò,et al.  The BioMart community portal: an innovative alternative to large, centralized data repositories , 2015, Nucleic Acids Res..

[26]  C. Mungall,et al.  Gene Ontology Consortium : going forward The Gene Ontology , 2015 .

[27]  Cheryl A Murphy,et al.  Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology. , 2015, Chemosphere.

[28]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[29]  V. Armstrong,et al.  The Assessment and Management of Industrial Chemicals in Canada , 2007 .

[30]  Ramakrishnan Srikant,et al.  Fast Algorithms for Mining Association Rules in Large Databases , 1994, VLDB.

[31]  R. Altman,et al.  Pharmacogenomics Knowledge for Personalized Medicine , 2012, Clinical pharmacology and therapeutics.

[32]  Thorsten Meinl,et al.  KNIME: The Konstanz Information Miner , 2007, GfKl.

[33]  Stephen W. Edwards,et al.  Reverse engineering adverse outcome pathways , 2011, Environmental toxicology and chemistry.

[34]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[35]  Stephen W. Edwards,et al.  Identification and Prioritization of Relationships between Environmental Stressors and Adverse Human Health Impacts , 2015, Environmental health perspectives.

[36]  David Dix,et al.  A Computational Model Predicting Disruption of Blood Vessel Development , 2013, PLoS Comput. Biol..

[37]  David M. Reif,et al.  Environmental Impact on Vascular Development Predicted by High-Throughput Screening , 2011, Environmental health perspectives.

[38]  Das Amrita,et al.  Mining Association Rules between Sets of Items in Large Databases , 2013 .

[39]  Susumu Goto,et al.  Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..

[40]  Stephen W. Edwards,et al.  Systems biology and mode of action based risk assessment. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  Shannon M. Bell,et al.  Building associations between markers of environmental stressors and adverse human health impacts using frequent itemset mining , 2014, SDM.

[42]  Natàlia Garcia-Reyero,et al.  Are adverse outcome pathways here to stay? , 2015, Environmental science & technology.

[43]  K. E. Tollefsena,et al.  Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA) , 2018 .

[44]  Jim Thurmond,et al.  FlyBase: introduction of the Drosophila melanogaster Release 6 reference genome assembly and large-scale migration of genome annotations , 2014, Nucleic Acids Res..

[45]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database's 10th year anniversary: update 2015 , 2014, Nucleic Acids Res..

[46]  David M. Reif,et al.  In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project , 2009, Environmental health perspectives.

[47]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[48]  Monte Westerfield,et al.  ZFIN, the Zebrafish Model Organism Database: increased support for mutants and transgenics , 2012, Nucleic Acids Res..

[49]  L. Stein,et al.  Annotating Cancer Variants and Anti-Cancer Therapeutics in Reactome , 2012, Cancers.

[50]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[51]  David J. Reiss,et al.  The Gaggle: An open-source software system for integrating bioinformatics software and data sources , 2006, BMC Bioinformatics.

[52]  Sharon Munn,et al.  Adverse outcome pathway (AOP) development I: strategies and principles. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  David M. Reif,et al.  Profiling Chemicals Based on Chronic Toxicity Results from the U.S. EPA ToxRef Database , 2008, Environmental health perspectives.

[54]  Igor Linkov,et al.  Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence. , 2015, Regulatory toxicology and pharmacology : RTP.

[55]  Janan T. Eppig,et al.  The mouse Gene Expression Database (GXD): 2014 update , 2013, Nucleic Acids Res..

[56]  Daniel J. Blankenberg,et al.  Galaxy: A Web‐Based Genome Analysis Tool for Experimentalists , 2010, Current protocols in molecular biology.

[57]  Martha L. Bulyk,et al.  UniPROBE, update 2015: new tools and content for the online database of protein-binding microarray data on protein–DNA interactions , 2014, Nucleic Acids Res..

[58]  Hiroshi Yamada,et al.  Open TG-GATEs: a large-scale toxicogenomics database , 2014, Nucleic Acids Res..

[59]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[60]  Kimberly Van Auken,et al.  WormBase 2014: new views of curated biology , 2013, Nucleic Acids Res..